Are CAR T cells the answer to myasthenia gravis therapy?
Gespeichert in:
| Veröffentlicht in: | Lancet neurology 2023-07, Vol.22 (7), p.545-546 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 546 |
|---|---|
| container_issue | 7 |
| container_start_page | 545 |
| container_title | Lancet neurology |
| container_volume | 22 |
| creator | Meisel, Andreas |
| description | |
| doi_str_mv | 10.1016/S1474-4422(23)00211-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2829424755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1474442223002119</els_id><sourcerecordid>2829424755</sourcerecordid><originalsourceid>FETCH-LOGICAL-c308t-891d047dfda423b19a60eda5af5ef99fcce5d6dc7bb8d288cfeb7514705fbf783</originalsourceid><addsrcrecordid>eNqFkMlOwzAQhi0EYn8EUCQucAh4jZ1TVVVsUiUklrPl2GMwapNiJ6C-PUlbOHDhNKPxN-NfH0InBF8STIqrJ8Ilzzmn9JyyC4wpIXm5hfY340Js__aU7qGDlN4HiCuyi_aYZIJRifeRGkfIJuPH7DmzMJulrH2DzNTpC2LWNtl8aVI_qYPJXqP5DKv3aBbL0RHa8WaW4HhTD9HLzfXz5C6fPtzeT8bT3DKs2lyVxGEunXeGU1aR0hQYnBHGC_Bl6a0F4QpnZVUpR5WyHiop-uBY-MpLxQ7R-fruIjYfHaRWz0Maopoami5pqmjJKZdC9OjZH_S96WLdpxsoxTjDsugpsaZsbFKK4PUihrmJS02wHtTqlVo9eNOU6ZVaXfZ7p5vrXTUH97v147IHRmsAeh2fAaJONkBtwYUIttWuCf988Q1g6YbN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2828343076</pqid></control><display><type>article</type><title>Are CAR T cells the answer to myasthenia gravis therapy?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Meisel, Andreas</creator><creatorcontrib>Meisel, Andreas</creatorcontrib><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(23)00211-9</identifier><identifier>PMID: 37353270</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acetylcholine receptors ; Acetylcholinesterase ; Antigens ; Autoantibodies ; Cell therapy ; Chemotherapy ; Chimeric antigen receptors ; Clinical trials ; Dendritic cells ; Disease ; Disease control ; Fc receptors ; Humans ; Immune system ; Immunoglobulin G ; Immunosuppressive agents ; Immunotherapy ; Lymphocytes ; Lymphocytes T ; Myasthenia gravis ; Myasthenia Gravis - therapy ; Neonates ; Neuromuscular junctions ; Placebo effect ; Placebos ; Plasma ; Plasma cells ; Skeletal muscle ; Steroid hormones ; T-Lymphocytes ; Thymectomy</subject><ispartof>Lancet neurology, 2023-07, Vol.22 (7), p.545-546</ispartof><rights>2023 Elsevier Ltd</rights><rights>2023. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c308t-891d047dfda423b19a60eda5af5ef99fcce5d6dc7bb8d288cfeb7514705fbf783</citedby><cites>FETCH-LOGICAL-c308t-891d047dfda423b19a60eda5af5ef99fcce5d6dc7bb8d288cfeb7514705fbf783</cites><orcidid>0000-0001-7233-5342</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1474442223002119$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37353270$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meisel, Andreas</creatorcontrib><title>Are CAR T cells the answer to myasthenia gravis therapy?</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><subject>Acetylcholine receptors</subject><subject>Acetylcholinesterase</subject><subject>Antigens</subject><subject>Autoantibodies</subject><subject>Cell therapy</subject><subject>Chemotherapy</subject><subject>Chimeric antigen receptors</subject><subject>Clinical trials</subject><subject>Dendritic cells</subject><subject>Disease</subject><subject>Disease control</subject><subject>Fc receptors</subject><subject>Humans</subject><subject>Immune system</subject><subject>Immunoglobulin G</subject><subject>Immunosuppressive agents</subject><subject>Immunotherapy</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Myasthenia gravis</subject><subject>Myasthenia Gravis - therapy</subject><subject>Neonates</subject><subject>Neuromuscular junctions</subject><subject>Placebo effect</subject><subject>Placebos</subject><subject>Plasma</subject><subject>Plasma cells</subject><subject>Skeletal muscle</subject><subject>Steroid hormones</subject><subject>T-Lymphocytes</subject><subject>Thymectomy</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkMlOwzAQhi0EYn8EUCQucAh4jZ1TVVVsUiUklrPl2GMwapNiJ6C-PUlbOHDhNKPxN-NfH0InBF8STIqrJ8Ilzzmn9JyyC4wpIXm5hfY340Js__aU7qGDlN4HiCuyi_aYZIJRifeRGkfIJuPH7DmzMJulrH2DzNTpC2LWNtl8aVI_qYPJXqP5DKv3aBbL0RHa8WaW4HhTD9HLzfXz5C6fPtzeT8bT3DKs2lyVxGEunXeGU1aR0hQYnBHGC_Bl6a0F4QpnZVUpR5WyHiop-uBY-MpLxQ7R-fruIjYfHaRWz0Maopoami5pqmjJKZdC9OjZH_S96WLdpxsoxTjDsugpsaZsbFKK4PUihrmJS02wHtTqlVo9eNOU6ZVaXfZ7p5vrXTUH97v147IHRmsAeh2fAaJONkBtwYUIttWuCf988Q1g6YbN</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Meisel, Andreas</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7233-5342</orcidid></search><sort><creationdate>202307</creationdate><title>Are CAR T cells the answer to myasthenia gravis therapy?</title><author>Meisel, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c308t-891d047dfda423b19a60eda5af5ef99fcce5d6dc7bb8d288cfeb7514705fbf783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Acetylcholine receptors</topic><topic>Acetylcholinesterase</topic><topic>Antigens</topic><topic>Autoantibodies</topic><topic>Cell therapy</topic><topic>Chemotherapy</topic><topic>Chimeric antigen receptors</topic><topic>Clinical trials</topic><topic>Dendritic cells</topic><topic>Disease</topic><topic>Disease control</topic><topic>Fc receptors</topic><topic>Humans</topic><topic>Immune system</topic><topic>Immunoglobulin G</topic><topic>Immunosuppressive agents</topic><topic>Immunotherapy</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Myasthenia gravis</topic><topic>Myasthenia Gravis - therapy</topic><topic>Neonates</topic><topic>Neuromuscular junctions</topic><topic>Placebo effect</topic><topic>Placebos</topic><topic>Plasma</topic><topic>Plasma cells</topic><topic>Skeletal muscle</topic><topic>Steroid hormones</topic><topic>T-Lymphocytes</topic><topic>Thymectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meisel, Andreas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meisel, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are CAR T cells the answer to myasthenia gravis therapy?</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2023-07</date><risdate>2023</risdate><volume>22</volume><issue>7</issue><spage>545</spage><epage>546</epage><pages>545-546</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37353270</pmid><doi>10.1016/S1474-4422(23)00211-9</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-7233-5342</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1474-4422 |
| ispartof | Lancet neurology, 2023-07, Vol.22 (7), p.545-546 |
| issn | 1474-4422 1474-4465 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2829424755 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Acetylcholine receptors Acetylcholinesterase Antigens Autoantibodies Cell therapy Chemotherapy Chimeric antigen receptors Clinical trials Dendritic cells Disease Disease control Fc receptors Humans Immune system Immunoglobulin G Immunosuppressive agents Immunotherapy Lymphocytes Lymphocytes T Myasthenia gravis Myasthenia Gravis - therapy Neonates Neuromuscular junctions Placebo effect Placebos Plasma Plasma cells Skeletal muscle Steroid hormones T-Lymphocytes Thymectomy |
| title | Are CAR T cells the answer to myasthenia gravis therapy? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T05%3A04%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20CAR%20T%20cells%20the%20answer%20to%20myasthenia%20gravis%20therapy?&rft.jtitle=Lancet%20neurology&rft.au=Meisel,%20Andreas&rft.date=2023-07&rft.volume=22&rft.issue=7&rft.spage=545&rft.epage=546&rft.pages=545-546&rft.issn=1474-4422&rft.eissn=1474-4465&rft_id=info:doi/10.1016/S1474-4422(23)00211-9&rft_dat=%3Cproquest_cross%3E2829424755%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2828343076&rft_id=info:pmid/37353270&rft_els_id=S1474442223002119&rfr_iscdi=true |